Amid the declining clinical severity of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and diminishing public uptake of annual coronavirus disease 2019 (Covid-19) vaccines, ...

The drug showed promising results in an international study involving nearly 2,400 participants, and the U.S. Food and Drug Administration is expected to make an approval decision for it in June ...

2024-2025 COVID-19 vaccines reduced hospitalization risk by 40% against JN.1 lineage variants. COVID-19 is still a public threat and health concern. Between 2024 and 2025, an estimated 380,000 to ...

Currently available clinical trial data doesn’t demonstrate that the drug is effective against COVID-19 in humans, the FDA says. As we’ve reported, the ivermectin debate has persisted since the ...

Changes in the vaccine advisory process in the United States have disrupted immunization guidance, which reinforces the need for independent evidence review to inform decisions regarding immunization ...

A major new study examining the 2023-2024 COVID-19 vaccines shows moderate protection that works best in the first few months but weakens considerably over time. The research, published in JAMA ...

PORTLAND Ore. (KPTV) - With flu season right around the corner, many people are trying to get their annual vaccines - but folks in Oregon say they have not been able to get the latest version of the ...

COVID-19 is no longer one of the top 10 causes of death in the U.S. Early data on deaths in 2024, published by the Centers for Disease Control and Prevention, show that COVID dropped from the list for ...